Finzati - Logo
ADMA logo

ADMA Biologics, Inc.

ADMA • Biotechnology
$9.62
▲ +0.04 (+0.42%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.22B
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 28.8%Positive revenue growth · 38.6%Positive free cash flow · 0.12Manageable debt level · 0.17Healthy liquidity · 6.71
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:58 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$9.62
Change0.42%
Shares Out230.34M
Market Cap$2.22B
Enterprise Value$2.28B
52W Range7.21 - 20.46
Beta0.73
P/E13.11
P/S4.33
P/B5.43
P/FCF12.87
EV/Sales4.44

Investment DNA

How strong this company looks for long-term investors

71
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
31/100
Why this score▼
Stable or improving margins · 28.8%Positive revenue growth · 38.6%Positive free cash flow · 0.12Manageable debt level · 0.17Healthy liquidity · 6.71

Analyst view

Analyst sentiment and price target

ADMA
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
95/100
Bullish
Bullish
9
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$17.00
Mean
$18.67
Median
$18.00
High
$21.00

Company Overview

IPO: 10/17/2013
Industry: Biotechnology
P/B i: 5.43
Debt / Equity i: 0.17
Operating Margin: 37.53%
Net Margin: 28.80%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.17
Current Ratio: 6.71
Quick Ratio: 3.74
Status: Strong

Insider Transactions

Recent executive and insider activity

Kestenberg-Messina Kaitlin M.
Transaction: 07/24/2026
SELL
Change
-3,177
Price
$8.37
Filing
07/28/2026
Type
SELL
Kohler Terry
Transaction: 07/16/2026
BUY
Change
+136,363
Price
$8.81
Filing
07/17/2026
Type
BUY
Kohler Terry
Transaction: 07/16/2026
BUY
Change
+85,130
Price
Not reported
Filing
07/17/2026
Type
BUY